REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 15th, 2013 • WP X Biologics LLC • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 15th, 2013 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) is made and entered into as of May 14, 2013, by and between China Biologic Products, Inc., a Delaware corporation (the “Company”) and WP X Biologics LLC (the “Purchaser”).
AGREEMENTAgreement • May 15th, 2013 • WP X Biologics LLC • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 15th, 2013 Company Industry JurisdictionThis AGREEMENT (this “Agreement”) is entered into as of May 14, 2013, by and among WP X Biologics LLC, a Delaware limited liability company (“WP X”), Ms. Lin Ling Li, a Hong Kong resident with Hong Kong ID number of R330968(0) (“Ms. Li”) and Mr. Ze Qin Lin, a Hong Kong resident with Hong Kong ID number of P774319(3) and husband of Ms. Li (“Mr. Lin”). WP X, Ms. Li and Mr. Lin are hereinafter referred to as the “Parties” and each a “Party”.
JOINT FILING AGREEMENTJoint Filing Agreement • May 15th, 2013 • WP X Biologics LLC • Biological products, (no disgnostic substances)
Contract Type FiledMay 15th, 2013 Company IndustryTHIS JOINT FILING AGREEMENT is entered into as of May 15, 2013, by and among the parties hereto. The undersigned hereby agree that the Statement on the amendment to the Schedule 13D with respect to the common stock, par value $0.0001 per share (the “Common Stock”) of China Biologic Products, Inc., to which this agreement is attached as an exhibit, and any amendment thereafter signed by each of the undersigned shall be (unless otherwise determined by the undersigned) filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.